Posted on July 1, 2021 |
By 340B Matters In the complex drug-pricing marketplace lies a murky underworld of pharmacy benefit managers (PBMs). Ostensibly, these companies negotiate lower drug pricing for insurers and (ideally) patients. They’...
Posted on June 18, 2021 |
By 340B Matters In July 2020, six huge drug companies fired the first salvo in a war against a federal program that helps safety-net healthcare providers care for the underserved. Their ...
Posted on May 26, 2021 |
By 340B Matters The Biden administration has finally acted against a reprehensible cabal of pharmaceutical companies unlawfully overcharging safety-net healthcare providers in the federal 340B Drug Discount Program. On May 17, ...
Posted on May 11, 2021 |
By 340B Matters The drug industry has an army of public relations suits busy spinning the world as Big Pharma sees it. Don’t be a patsy for one of ...
Posted on April 21, 2021 |
By 340B Matters Six huge pharmaceutical companies are breaking the law, denying safety-net hospitals and clinics lower-priced medications required by the federal 340B Drug Discount Program. Meanwhile, they’ve reaped ...